Key facts
- Turbett Surgical’s last known valuation is $44.5M (Jan 2026).
- It has raised $26.1M across 1 recorded rounds; the latest was Seed Round ($1.0M) in Feb 2022.
- Notable investors include JPMorgan Life Sciences Private Capital, RIT Venture Creations Incubator.
- Turbett Surgical has filed 1 Form D with the SEC, most recently Feb 2022 ($1.0M sold to 21 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Turbett Surgical
Funding rounds
1 roundsAbout Turbett Surgical
Developer of an instrument pod intended to offer instrument sterilization for hospitals. The company's device helps to sterilize surgery instruments in a simpler way which can be done by one person and eliminates the repetitive chores of reprocessing and delivering instruments to the sterile field, enabling hospitals to remove the loss of time which increases throughput and reduces the overall turnover.
- Sector
- Healthcare
- HQ
- Henrietta, NY, United States
- Founded
- 2013
- Employees
- 15
- Website
- turbettsurgical.com/
- Ownership
- Privately Held (backing)
Turbett Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Turbett Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Turbett Surgical in its N-PORT filings yet. We sweep new filings monthly.